Suzhou HUYUN plans to raise 12 million yuan to develop new drugs

Suzhou HUYUN (833464) released the targeted issuance plan on the evening of October 21 The company plans to issue no more than 827600 shares to no more than 35 investors at a price of 14.5 yuan / share It is expected to raise 12 million yuan The raised funds are mainly used for research and development of new drugs and supplement the company's working capital to achieve the company's overall strategy and improve the company's market competitiveness
http://file.neeq.com.cn/upload/disclosure/2015/2015-10-21/1445413759_655690.pdf
Suzhou HUYUN Tumor Research Center Co., Ltd focuses on the R & D and production of treatment drugs for autoimmune diseases, cardiovascular and cerebrovascular diseases and tumors In this field, HUYUN has screened more than ten effective lead compounds, one of which will be applied for clinical research, two of which are in preclinical research, and two of which will be included in drug research HUYUN is forming Pipeline.